Skip to main content
. 2022 May 12;1868(9):166432. doi: 10.1016/j.bbadis.2022.166432

Table 2.

Mutated T cell epitopes in spike protein from variants of SARS-COV-2.

CD8 native epitope CD8 Mutant epitope Variants
AEHVNNSY AEYVNNSY P.1, B.1.1.529
DGVYFASTEK DGVYFASIEK B.1.617.2.1, B.1.1.529
DSKVGGNYNY DSKVSGNYNY B.1.1.529
GEVFNATRF DEVFNATRF B.1.1.529
FQFCNDPFL FQFCNYPFL P.1
GVYFASTEK GVYFASIEK B.1.617.2.1, B.1.1.529
GVYYHKNNK DVYYHKNNK B.1.617.2.1
DHKNNK B.1.1.529
HVSGTNGTK SGTNGTK B.1.1.298
HVISGTNGTK B.1.1.529
IYKTPPIKDF IYKTPPIKYF B.1.1.529
KIADYNYKL NIADYNYKL B.1.617.2.1
TIADYNYKL P.1
KVGGNYNYLY KVGGNYNYRY B.1.617.2.1
KVGGNYNYLF B.1.1.298
KVSGNYNYLY B.1.1.529
LGAENSVAY LGVENSVAY B.1.1.529
LPPAYTNSF LPSAYTNSF P.1
NASVVNIQK NASFVNIQK P.1, P.2
NESLIDLQEL NESLIDLQQL B.1.1.429
NSASFSTFK NLAPFFTFK B.1.1.529
NYNYLYRLF NYNYLFRLF B.1.1.298
NYNYRYRLF B.1.617.2.1
QELGKYEQY QQLGKYEQY B.1.1.429
QIAPGQTGK QIAPGQTGN B.1.617.2.1
QIAPGQTGT P.1
QTNSPRRAR QTNSRRRAR B.1.617.2.1
QTKSHRRAR B.1.1.529
RASANLAATK RASANLAAIK P.1
SFKEELDKY LFKEELDKY B.1.1.298
SIIAYTMSL SIIAYTMLL P.2
SPRRARSV SRRRARSV B.1.617.2.1
SHRRARSV B.1.1.529
SPRRARSVA SRRRARSVA B.1.617.2.1
SHRRARSVA B.1.1.529
SVLNDILSR SVLNDIFSR B.1.1.529
SWMESEFRVY SWMESGVY B.1.617.2.1
TEKSNIIRGW IEKSNIIRGW B.1.617.2.1, B.1.1.529
TPINLVRDL TPIIVREPEDL B.1.1.529
TVYDPLQPELDSFK TVYDPLQPELDLFK B.1.1.298
VGGNYNYLY VGGNYNYLF B.1.1.298
VGGNYNYRY B.1.617.2.1
VSGNYNYLY B.1.1.529
VLNDILSRL VLNDIFSRL B.1.1.529
VYDPLQPELDSF VYDPLQPELDLF B.1.1.298
WTAGAAAYY LTAGAAAYY B.1.617.2.1
YFQPRTFLL YLQPRTFLL B.1.617.2.1, B.1.1.298, P.1, B.1.1.429, P.2, B.1.1.529
YGFQPTNGV YGFQPTYGV P.1
YSFRPTYGV B.1.1.529
YNYLYRLFR YNYLFRLFR B.1.1.298
YNYRYRLFR B.1.617.2.1
YQDVNCTEV YQGVNCTEV B.1.617.2.1, B.1.1.298, P.1, B.1.1.429, P.2, B.1.1.529
YTMSLGAENSVAY YTMLLGAENSVAY P.2
YTMSLGVENSVAY B.1.1.529
YYHKNNKSW DHKNNKSW B.1.1.529
AENSVAYSNNSIAIP VENSVAYSNNSIAIP B.1.1.529
ARDLICAQKFNGLTV ARDLICAQKFKGLTV B.1.1.529
CAQKFNGLTVLPPLL CAQKFKGLTVLPPLL B.1.1.529
CEFQFCNDPFLGVYY CEFQFCNYPFLGVYY P.1
CEFQFCNDPFLDVYY B.1.617.2.1
CEFQFCNDPFLD B.1.1.529
CPFGEVFNATRFASV CPFDEVFNATRFASV B.1.1.529
CVADYSVLYNSASFS CVADYSVLYNLAPFF B.1.1.529
EIYQAGSTPCNGVEG EIYQAGSTPCNGVKG P.1
EIYQAGNTPCNGVKG P.2
EIYQAGSKPCNGVEG B.1.617.2.1
EIYQAGNKPCNGVAG B.1.1.529
FKIYSKHTPINLVRD FKIYSKHTPIIVREPED B.1.1.529
FNCYFPLQSYGFQPT FNCYFPLRSYSFRPT B.1.1.529
FNGLTVLPPLLTDEM FKGLTVLPPLLTDEM B.1.1.529
GINASVVNIQKEIDR GINASFVNIQKEIDR P.1, P.2
GKQGNFKNLREFVFK GKQGNFKNLSEFVFK P.1
HKNNKSWMESEFRVY HKNNKSWMESGVY B.1.617.2.1
IVRFPNITNLCPFGE IVRFPNITNLCPFDE B.1.1.529
KHTPINLVRDLPQGF KHTPIIVREPEDLPQGF B.1.1.529
LGVYYHKNNKSWMES LDVYYHKNNKSWMES B.1.617.2.1
LDHKNNKSWMES B.1.1.529
LMDLEGKQGNFKNLR LMDLEGKQGNFKNLS P.1
LPFFSNVTWFHAIHV LPFFSNVTWFHAI B.1.1.298
LPFFSNVTWFHVI B.1.1.529
LQPELDSFKEELDKY LQPELDLFKEELDKY B.1.1.298
LTGTGVLTESNKKFL LKGTGVLTESNKKFL B.1.1.529
NLLLQYGSFCTQLNR NLLLQYGSFCTQLKR B.1.1.529
NLVRDLPQGFSALEP IVREPEDLPQGFSALEP B.1.1.529
NPVLPFNDGVYFAST NPVLPFNDGVYFASI B.1.617.2.1, B.1.1.529
PINLVRDLPQGFSAL PIIVREPEDLPQGFSAL B.1.1.529
QELGKYEQYIKWPWY QQLGKYEQYIKWPWY B.1.1.429
QLIRAAEIRASANLAATK QLIRAAEIRASANLAAIK P.1
SASFSTFKCYGVSPT LAPFFTFKCYGVSPT B.1.1.529
SVLYNSASFSTFKCY SVLYNLAPFFTFKCY B.1.1.529
TPPIKDFGGFNFSQI TPPIKYFGGFNFSQI B.1.1.529
TQLNRALTGIAVEQD TQLKRALTGIAVEQD B.1.1.529
WNSNNLDSKVGGNYN WNSNKLDSKVSGNYN B.1.1.529
VNLTTRTQLPPAYTN VNFTNRTQLPSAYTN P.1
VNLRTRTQLPPAYTN B.1.617.2.1
VSSQCVNLTTRTQLP VSSQCVNFTNRTQLP P.1
VSSQCVNLRTRTQLP B.1.617.2.1
VVIKVCEFQFCNDPF VVIKVCEFQFCNYPF P.1
YNYLYRLFRKSNLKP YNYRYRLFRKSNLKP B.1.617.2.1
YNYLFRLFRKSNLKP B.1.1.298

Footnote: Positions with mutations are highlighted in red. Red highlighted residues in native epitopes indicate the deletions. Yellow highlighted mutated epitopes were not used for further HLA analysis due to their length (less than 8 or more than 15 residues).